Omalizumab treatment downregulates dendritic cell FcεRI expression
Top Cited Papers
Open Access
- 1 December 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 112 (6) , 1147-1154
- https://doi.org/10.1016/j.jaci.2003.10.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Rapid reduction of basophil FcεR1 expression by omalizumabJournal of Allergy and Clinical Immunology, 2003
- Flexibility of Mouse Classical and Plasmacytoid-derived Dendritic Cells in Directing T Helper Type 1 and 2 Cell DevelopmentThe Journal of Experimental Medicine, 2003
- Unraveling the mission of FcϵRI on antigen-presenting cellsJournal of Allergy and Clinical Immunology, 2003
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial AntigensThe Journal of Experimental Medicine, 2001
- Experience with monoclonal antibodies in allergic mediated disease: Seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2001
- Experiences with monoclonal antibody therapy for allergic asthma☆☆☆Journal of Allergy and Clinical Immunology, 2001
- Mechanisms of T Cell Peptide Epitope-Dependent Late Asthmatic ReactionsInternational Archives of Allergy and Immunology, 2001
- Reciprocal Control of T Helper Cell and Dendritic Cell DifferentiationScience, 1999
- Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997